Q: I have room to add one of these to my TFSA now and another in January. I see 2 of these are in your model portfolios. In what order would you purchase these 3 or am I getting too picky ? SCORE had a huge recent run up; would you wait for it to settle down. I like it’s theme and strong insider ownership Thanks
Derek
Q: you seemed to have liked this stock in April recently had a huge break out i dont mind taking a calculated risk i like what they do and as far as i can see the stock looks good what are your thoughts going forward
Q: Atara Biotherapeutics (NASDAQ:ATRA) has announced presentation of preclinical data of ATA3219 at American Society of Hematology.
Their allogeneic CAR T-cell therapy targeting CD19, Bayer has also just entered into an exclusive worldwide license agreement, for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors with Atara.
What is your opinion on this company and it's medium and long term investment potential.
Q: Hi there,
So another stock that's popped up on my radar thanks to Twitter. KBNT - have you heard of it? Any thoughts on it? Currently have a small holding in my TFSA, shall I add? Morningstar thinks its under FV. Many thanks as always.
Q: Hello Peter,
With Xebec's bought deal at $5.80 per share with latest acquisition of Hygear, why are investors paying over $7 today? What am I missing? Would green renewables be a good bet given what is happening to Xebec? Also, why is Score dipping given the positive news on its outlook. Also, is good natured products a stock worth dipping into ? Thanks very much.
MTRX and KABN stock prices are exploding upwards. Apparently the companies interact. Any insights into the reason for the price action, nature of company interaction and merit/substance behind the striking moves.